Table 1: Open in new tab Patient...

Data

Total

Age

66.8 ± 9.2 (37–82)

Male gender

AF characteristics

Paroxysmal

Persistent

Long-lasting persistent

AF duration (median; IQR in months)

27 (10–55)

EHRA

Class I

Class II

Class III

Class IV

History of TIA

History of PRIND

History of stroke

History of AF ablation

History of AF surgery

History of AF intervention

Comorbidities

NYHA

Class I

Class II

Class III

Class IV

Systemic hypertension

Renal insufficiency

Diabetes

COPD

Preoperative medication

Aspirin

ACE inhibitor

Loop diuretics

Class I antiarrhythmics

Sotalol

Coumadin

β-Blocker

AT1 receptor blocker

Amiodarone

Digitalis

Statin

Dronedarone

Preoperative characteristics

LVEF

55.5 ± 12.6 (21–90)

LA dimensions (parasternal)

4.8 ± 0.8 (3.4–5.1)

Mitral regurgitation

None

Grade I

Grade II

Grade III

Grade IV

Operative characteristics

CABG

Ascending aortic replacement

Off-pump

Table 1:

Open in new tab

Patient demographics, preoperative and operative characteristics of the patient population

Data	Total
n	99
Age	66.8 ± 9.2 (37–82)
Male gender	73
AF characteristics
Paroxysmal	29
Persistent	18
Long-lasting persistent	52
AF duration (median; IQR in months)	27 (10–55)
EHRA
Class I	57
Class II	26
Class III	15
Class IV	1
History of TIA	10
History of PRIND	0
History of stroke	10
History of AF ablation	11
History of AF surgery	2
History of AF intervention	9
Comorbidities
NYHA
Class I	19
Class II	40
Class III	36
Class IV	4
Systemic hypertension	79
Renal insufficiency	17
Diabetes	24
COPD	9
Preoperative medication
Aspirin	36
ACE inhibitor	63
Loop diuretics	53
Class I antiarrhythmics	9
Sotalol	1
Coumadin	43
β-Blocker	77
AT1 receptor blocker	14
Amiodarone	10
Digitalis	33
Statin	51
Dronedarone	5
Preoperative characteristics
LVEF	55.5 ± 12.6 (21–90)
LA dimensions (parasternal)	4.8 ± 0.8 (3.4–5.1)
Mitral regurgitation
None	34
Grade I	23
Grade II	18
Grade III	20
Grade IV	4
Operative characteristics
CABG	40
MV	37
AV	31
TV	14
Ascending aortic replacement	12
Off-pump	4

Data	Total
n	99
Age	66.8 ± 9.2 (37–82)
Male gender	73
AF characteristics
Paroxysmal	29
Persistent	18
Long-lasting persistent	52
AF duration (median; IQR in months)	27 (10–55)
EHRA
Class I	57
Class II	26
Class III	15
Class IV	1
History of TIA	10
History of PRIND	0
History of stroke	10
History of AF ablation	11
History of AF surgery	2
History of AF intervention	9
Comorbidities
NYHA
Class I	19
Class II	40
Class III	36
Class IV	4
Systemic hypertension	79
Renal insufficiency	17
Diabetes	24
COPD	9
Preoperative medication
Aspirin	36
ACE inhibitor	63
Loop diuretics	53
Class I antiarrhythmics	9
Sotalol	1
Coumadin	43
β-Blocker	77
AT1 receptor blocker	14
Amiodarone	10
Digitalis	33
Statin	51
Dronedarone	5
Preoperative characteristics
LVEF	55.5 ± 12.6 (21–90)
LA dimensions (parasternal)	4.8 ± 0.8 (3.4–5.1)
Mitral regurgitation
None	34
Grade I	23
Grade II	18
Grade III	20
Grade IV	4
Operative characteristics
CABG	40
MV	37
AV	31
TV	14
Ascending aortic replacement	12
Off-pump	4

TIA: transient ischaemic attack; PRIND: prolonged reversible ischaemic neurological deficit; AF: atrial fibrillation; LVEF: left ventricular ejection fraction; LA: left atrium; CABG: coronary artery bypass graft surgery; MV: mitral valve surgery; AV: aortic valve surgery; TV: tricuspid valve surgery; NYHA: New York Heart Association class; COPD: chronic obstructive pulmonary disease; ACE: angiotensin-converting enzyme; IQR: interquartile range.

This Feature Is Available To Subscribers Only